Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 2-(4-methoxyphenyl)-4H-thieno[3,2-b]pyrrole-5-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1314022-93-9

Post Buying Request

1314022-93-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1314022-93-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1314022-93-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,0,2 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1314022-93:
(9*1)+(8*3)+(7*1)+(6*4)+(5*0)+(4*2)+(3*2)+(2*9)+(1*3)=99
99 % 10 = 9
So 1314022-93-9 is a valid CAS Registry Number.

1314022-93-9Relevant academic research and scientific papers

Singlet oxygen generation by novel NIR BODIPY dyes

Awuah, Samuel G.,Polreis, Jason,Biradar, Vidya,You, Youngjae

, p. 3884 - 3887 (2011)

Five novel near-infrared BODIPY dyes were prepared for improved singlet oxygen generation using thiophene and bromine. Theoretical, optical, photostable, and singlet oxygen generation characteristics of these dyes were assessed. Predicted excitation energ

PEG conjugated BODIPY-Br2 as macro-photosensitizer for efficient imaging-guided photodynamic therapy

Ruan, Zheng,Zhao, Yangyang,Yuan, Pan,Liu, Le,Wang, Yucai,Yan, Lifeng

, p. 753 - 762 (2018/02/09)

Drug-free biocompatible nanoparticles with photosensitizers as both diagnostic and therapy agents represent an emerging approach for imaging-guided photodynamic therapy (PDT). Here, a NSH-active boron-dipyrromethene (BODIPY) derivative with a bromine substituted (BODIPY-Br2, for simplicity, BDP-Br) photosensitizer was synthesized; it showed a high ability of generating reactive oxygen species (ROS) upon irradiation for PDT and near infrared fluorescence imaging ability. Then, a simple PEGylated BDP-Br (PEG-BDP) as a kind of macro photosensitizer was prepared which showed superior cellular uptake ability, high efficiency of imaging, and curing with PDT therapy in vitro and in vivo. After administration with a 4T1 orthotopic tumor model, the resultant PEG-BDP showed prolonged blood circulation and preferential tumor accumulation compared with free BDP-Br molecules. Once accumulated in tumor tissues, therapeutic effects of PEG-BDP could significantly suppress primary tumor growth and has no evident side effects at a weak irradiation energy as low as 35 mW cm-2 for 20 minutes. The designation of this simple structure macro photosensitizer agent provides new avenues for efficient imaging-guided cancer PDT.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1314022-93-9